Horizon Technology Finance Corporation (NASDAQ: HRZN) (“Horizon”), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries, announced today it has provided a $20 million venture loan facility to Encore Dermatology, Inc. (“Encore”), of …
Encore Dermatology Inc. announced today that it has acquired rights for SERNIVO® (betamethasone dipropionate) Spray, 0.05%, as well as rights to market and distribute TRIANEX® 0.05% (Triamcinolone Acetonide Ointment, USP) and PROMISEB® Topical Cream in the United States from Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY), through its wholly owned subsidiary Promius …
Dr. Reddy’s Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”), through its wholly owned subsidiary Promius Pharma, LLC, announces the sale of its rights for SERNIVO® (betamethasone dipropionate) Spray, 0.05% and assignment of its rights to market and distribute, PROMISEB® Topical Cream and TRIANEX® 0.05% …
Pennsylvania’s life sciences industry honored its own Wednesday night as awards where handed out at Life Sciences Pennsylvania’s annual dinner. The event at the Pennsylvania Convention Center drew a record crowd of more than 1,300 people. Paul Touhey, Operating Partner at 1315 Capital awarded the John Nash MedTech Leadership Award.
Onkos Surgical, Inc. announced today that it has partnered with Promimic AB, the world’s leading innovator in nano surface modification, to commercialize Promimic’s proprietary Hydroxyapatite (HA) Surface Technologies in Limb Salvage Surgery.
9. Since its inception in October 2015, the company has already supported over 200 surgeons and over 1,100 limbs have been saved using Onkos products.
The Private Equity Women Investor Network (PEWIN), the pre-eminent organization for senior-level women investment professionals in private equity, today announced that its Members – Adele Oliva (1315 Capital), Hollie Haynes (Luminate Capital Partners), Kristina Heinze (ParkerGale) and Kate Mitchell (Scale Venture Partners) – have each successfully closed a new fund.
With more than three decades in the pharmaceutical and biotechnology industries, Mary Fisher is a force to be reckoned with in aesthetics. Her CV includes leadership positions at Acorda Therapeutics, Cephalon, Immunex, and Boehringer Ingelheim.
Onkos Surgical, Inc. announced today that it has launched MyTray, a fully integrated personal surgical planning solution that leverages preoperative imaging and the precision of surgeon specific procedural requirements; all delivered in the convenience of personalized instrumentation trays. The MyTray solution is powered by the company’s novel digital health platform called uDesign™.
Colorescience® announces the launch of PEP UP™ Collagen Renewal Face & Neck Treatment, a powerful clinically-tested treatment that trains skin to build its own healthy collagen to defend against the visible signs of aging.